Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2022-03-02
Product name
DYAZIDE CAPSULES
Product Synonyms
DYAZIDE CAPSULES 25 MG/37.5 MG * TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FORMULATED PRODUCT
supplier name
GlaxoSmithKline Korea
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H335, H413
Hazard statements
Code
Statements
H335
May cause respiratory irritation
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Specific target organ toxicity following single Category 3 respiratory tract irritation exposure
Environmental hazards
Hazardous to the aquatic environment, Category 4
Long term hazards
B. Warning label items including precautionary statement
Signal word
Warning
Hazard statements
H335 May cause respiratory irritation. H413 May cause long lasting harmful effects to aquatic life.
Prevention
P261 Avoid breathing dust. P261 Avoid breathing vapours. P271 Use only outdoors or in a well-ventilated area. P273 Avoid release to the environment.
Response
P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P312 Call a POISON CENTRE or doctor/physician if you feel unwell.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations. C. Other hazards not included Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. in the hazard category criteria (e.g. dust explosion hazard)
Additional information
7 % of the mixture consists of component(s) of unknown acute oral toxicity. 99 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 99 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 98 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
